DK1512004T3 - Fremgangsmåde til kortlægning og eliminering af T-celleepitoper - Google Patents

Fremgangsmåde til kortlægning og eliminering af T-celleepitoper

Info

Publication number
DK1512004T3
DK1512004T3 DK03740219T DK03740219T DK1512004T3 DK 1512004 T3 DK1512004 T3 DK 1512004T3 DK 03740219 T DK03740219 T DK 03740219T DK 03740219 T DK03740219 T DK 03740219T DK 1512004 T3 DK1512004 T3 DK 1512004T3
Authority
DK
Denmark
Prior art keywords
epitopes
identification
mapping
eliminating
cell epitopes
Prior art date
Application number
DK03740219T
Other languages
Danish (da)
English (en)
Inventor
Matthew Baker
Francis J Carr
Graham Carter
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29724386&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1512004(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK1512004T3 publication Critical patent/DK1512004T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK03740219T 2002-06-11 2003-06-11 Fremgangsmåde til kortlægning og eliminering af T-celleepitoper DK1512004T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02012919 2002-06-11

Publications (1)

Publication Number Publication Date
DK1512004T3 true DK1512004T3 (da) 2006-06-06

Family

ID=29724386

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03740219T DK1512004T3 (da) 2002-06-11 2003-06-11 Fremgangsmåde til kortlægning og eliminering af T-celleepitoper

Country Status (16)

Country Link
EP (1) EP1512004B1 (zh)
JP (1) JP2005529170A (zh)
CN (1) CN100401064C (zh)
AT (1) ATE320603T1 (zh)
AU (1) AU2003273679A1 (zh)
BR (1) BR0311720A (zh)
CA (1) CA2489180A1 (zh)
DE (1) DE60304040T2 (zh)
DK (1) DK1512004T3 (zh)
ES (1) ES2257680T3 (zh)
MX (1) MXPA04012209A (zh)
PL (1) PL371675A1 (zh)
PT (1) PT1512004E (zh)
RU (1) RU2334235C2 (zh)
WO (1) WO2003104803A2 (zh)
ZA (1) ZA200500214B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1594965A2 (en) * 2003-02-18 2005-11-16 MERCK PATENT GmbH Fusion proteins of interferon alpha muteins with improved properties
BRPI0508670B1 (pt) 2004-03-19 2023-01-24 Merck Patent Gmbh Proteínas buganina modificadas, citotoxinas, usos das referidas citotoxinas para o tratamento de câncer, composição farmacêutica, processo de preparação de produto farmacêutico, ácidos nucléicos e peptídeos de epítopo de célula t
FR2940451B1 (fr) 2008-12-18 2014-09-12 Proteus Procede d'evaluation de l'immunogenicite des proteines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001349A (en) * 1995-02-22 1999-12-14 Therion Biologics Corporation Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
US5945401A (en) * 1995-06-23 1999-08-31 Conlon; Paul J. Peptide analogues of the 65KD isoform of human glutamic acid decarboxylase and uses thereof
US6165460A (en) * 1995-07-10 2000-12-26 Therion Biologics Corporation Generation of immune responses to prostate-specific antigen (PSA)
ES2314515T3 (es) * 1996-03-21 2009-03-16 Circassia Limited Peptidos cripticos y metodo para su identificacion.
US5750356A (en) * 1996-05-31 1998-05-12 Anergen, Inc. Method for monitoring T cell reactivity
JP2002512624A (ja) * 1997-05-21 2002-04-23 バイオベーション リミテッド 非免疫原性タンパク質の製造方法
EP1051432B1 (en) * 1998-12-08 2007-01-24 Biovation Limited Method for reducing immunogenicity of proteins
DE60144399D1 (de) * 2000-10-02 2011-05-19 Danisco Us Inc Methode zur bestimmung der immunogenität von proteinen, die eine veränderte immunantwort hervorrufen

Also Published As

Publication number Publication date
ZA200500214B (en) 2006-02-22
CN100401064C (zh) 2008-07-09
WO2003104803A2 (en) 2003-12-18
AU2003273679A1 (en) 2003-12-22
PL371675A1 (en) 2005-06-27
WO2003104803A3 (en) 2004-04-15
RU2334235C2 (ru) 2008-09-20
CA2489180A1 (en) 2003-12-18
BR0311720A (pt) 2005-03-01
ATE320603T1 (de) 2006-04-15
DE60304040T2 (de) 2006-09-28
ES2257680T3 (es) 2006-08-01
CN1659437A (zh) 2005-08-24
MXPA04012209A (es) 2005-02-25
EP1512004B1 (en) 2006-03-15
PT1512004E (pt) 2006-08-31
RU2005100758A (ru) 2006-01-20
EP1512004A2 (en) 2005-03-09
DE60304040D1 (de) 2006-05-11
JP2005529170A (ja) 2005-09-29

Similar Documents

Publication Publication Date Title
DK1553975T3 (da) Optimerede Fc-varianter og fremgangsmåder til generering heraf.
NO20054351L (no) Monoklonalt antistoff og hybridom som produserer dette
DK1259547T3 (da) Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf
DK1532261T3 (da) Fremgangsmåder og DNA-konstrukter til produktion af polypeptider med højt udbytte
DK1187591T3 (da) IBD-associerede mikrobielle antigener og fremgangsmåder til at anvende samme
CY1110868T1 (el) Ελαχιστη αλληλουχια dna που δρα ως μονωτης της χρωματινης και η χρηση της στην πρωτεϊνικη εκφραση
DK1699822T3 (da) IL-7-fusionsproteiner med antistofdele, fremstilling deraf og anvendelse deraf
ECSP067073A (es) Anticuerpos anti-il-13 y complejos
NO20014584L (no) Proteinisolering og -analyse
DK1697523T3 (da) Ekspressionsvektor til antibiotikafri ekspression
AU2003224674A8 (en) Compounds and methods for analyzing the proteome
ATE517340T1 (de) Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren
DK1328547T3 (da) Identifikation og modifikation af immundominante epitoper i polypeptider
WO2003068941A3 (en) Modulation of immune response by non-peptide binding stress response polypeptides
BRPI0512798A (pt) molécula de ácido nucleico recombinante, célula, método para produzir uma proteìna de interesse, uso de uma seqüência de ácido nucleico tendo atividade anti-repressora, métodos para gerar uma célula hospedeira expressando dois polipeptìdios de interesse, e para expressar dois polipeptìdios de interesse
ZA200500214B (en) Method for mapping and eliminating T-cell epitopes.
DK0840620T3 (da) IL-8-antagonister til behandling af astma
ATE316577T1 (de) Das goodpasture-antigen bindende protein
AU2174002A (en) Method for analyzing proteins
DK1506235T3 (da) Fremgangsmåde til produktion af monoklonale antistoffer
DK1141026T3 (da) Sammensætninger og fremgangsmåder til frembringelse af monoklonale antistoffer repræsentative for en specifik celletype
MY144766A (en) Plant virus coat fusion proteins with gdf8 epitopes and vaccines thereof
WO2004003221A3 (en) Methods for peptide-protein binding prediction
DK1386160T3 (da) Fremgangsmåde til påvisning af blodcelle-antigener og antistoffer rettet mod disse
DK1572931T3 (da) Fremgangsmåder og sammensætninger til modulering og påvisning af WISP-aktivitet